ZA842984B - Pharmaceutical preparation containing purified fibronectin - Google Patents

Pharmaceutical preparation containing purified fibronectin

Info

Publication number: ZA842984B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical preparation; preparation containing; containing purified; fibronectin; purified fibronectin
Prior art date: 1983-04-28

Application number

ZA842984A

Other languages

English (en)

Inventor

Ricardo H Landaburu

Robert H Yue

David L Farb

Bernard N Violand

Original Assignee

Armour Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-04-28

Filing date

1984-04-19

Publication date

1984-11-28

1984-04-19 Application filed by Armour Pharma filed Critical Armour Pharma

1984-11-28 Publication of ZA842984B publication Critical patent/ZA842984B/xx

Links

102000016359 Fibronectins Human genes 0.000 title abstract 3
108010067306 Fibronectins Proteins 0.000 title abstract 3
239000000825 pharmaceutical preparation Substances 0.000 title 1
150000001720 carbohydrates Chemical class 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Immunology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA842984A 1983-04-28 1984-04-19 Pharmaceutical preparation containing purified fibronectin ZA842984B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US48962483A	1983-04-28	1983-04-28

Publications (1)

Publication Number	Publication Date
ZA842984B true ZA842984B (en)	1984-11-28

Family

ID=23944603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA842984A ZA842984B (en)	1983-04-28	1984-04-19	Pharmaceutical preparation containing purified fibronectin

Country Status (7)

Country	Link
EP (1)	EP0124018B1 (fr)
JP (1)	JPS59206312A (fr)
AT (1)	ATE31023T1 (fr)
AU (1)	AU561590B2 (fr)
CA (1)	CA1214102A (fr)
DE (1)	DE3467706D1 (fr)
ZA (1)	ZA842984B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61103836A (ja) *	1984-10-24	1986-05-22	Green Cross Corp:The	フイブロネクチン製剤
AT385658B (de) *	1985-03-28	1988-05-10	Serotherapeutisches Inst Wien	Verfahren zur herstellung einer fuer die anwendung beim menschen geeigneten fibronektinloesung
US4929442A (en) *	1986-09-26	1990-05-29	Exovir, Inc.	Compositions suitable for human topical application including a growth factor and/or related materials
DE68908175T2 (de) *	1988-05-27	1994-03-03	Centocor Inc	Gefriergetrocknete formulierung für antikörperprodukte.
JPH03504499A (ja) *	1988-05-27	1991-10-03	セントカー・インコーポレーテツド	抗体試薬のための配合物
IL93618A0 (en) *	1989-03-06	1990-12-23	Lilly Co Eli	Improved diluent formulation for daptomycin
CA2024046A1 (fr) *	1989-09-28	1991-03-29	Alberto Ferro	Interferons stabilises
IE64738B1 (en) *	1990-03-20	1995-09-06	Akzo Nv	Stabilized gonadotropin containing preparations
EP1958618A1 (fr) *	2007-02-15	2008-08-20	Octapharma AG	Procédé destiné à la lyophilisation par reconstitution optimisée de biopolymères
JP7110360B2 (ja)	2017-10-09	2022-08-01	テルモビーシーティーバイオテクノロジーズ，エルエルシー	凍結乾燥方法
CN113597532B (zh)	2019-03-14	2023-02-17	泰尔茂比司特生物技术有限公司	冻干容器填充固定装置、系统及使用方法
CN117860608A (zh) *	2023-12-28	2024-04-12	深圳柏垠生物科技有限公司	一种速溶型纤连蛋白冻干粉及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0035204B2 (fr) *	1980-03-05	1991-05-22	Miles Inc.	Compositions pasteurisées de protéines thérapeutiquement actives
US4305871A (en) *	1980-09-02	1981-12-15	Edward Shanbrom	Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
JPS5767520A (en) *	1980-10-13	1982-04-24	Katsuyuki Haranaka	Preparation of antitumor agent
JPS5967228A (ja) *	1982-10-07	1984-04-16	Green Cross Corp:The	寒冷不溶性グロブリンの凍結乾燥方法

1984
- 1984-04-17 DE DE8484104360T patent/DE3467706D1/de not_active Expired
- 1984-04-17 AT AT84104360T patent/ATE31023T1/de not_active IP Right Cessation
- 1984-04-17 EP EP84104360A patent/EP0124018B1/fr not_active Expired
- 1984-04-18 CA CA000452289A patent/CA1214102A/fr not_active Expired
- 1984-04-19 ZA ZA842984A patent/ZA842984B/xx unknown
- 1984-04-26 AU AU27402/84A patent/AU561590B2/en not_active Ceased
- 1984-04-26 JP JP59083038A patent/JPS59206312A/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2740284A (en)	1984-11-01
EP0124018B1 (fr)	1987-11-25
DE3467706D1 (en)	1988-01-07
CA1214102A (fr)	1986-11-18
ATE31023T1 (de)	1987-12-15
EP0124018A1 (fr)	1984-11-07
JPS59206312A (ja)	1984-11-22
AU561590B2 (en)	1987-05-14

Publication	Publication Date	Title
ZA872744B (en)	1988-11-30	Phenyl-piperazine anti-arrhythmia agents
DE3474511D1 (en)	1988-11-17	Pharmaceutical composition containing urokinase
EP0249078A3 (en)	1988-08-10	Optically active adsorbents
AU1206788A (en)	1988-09-01	Fabric softening composition
DE3467706D1 (en)	1988-01-07	Pharmaceutical preparation containing purified fibronectin
NZ211424A (en)	1988-09-29	Pharmaceutical compositions comprising 3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine
EP0137234A3 (en)	1987-08-19	Physiologically active compositions
GB8319546D0 (en)	1983-08-24	Pharmaceutical active salts
AU2131483A (en)	1985-05-23	Child's bed rocker
ZA884858B (en)	1989-03-29	Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiate-antagonistic activity
PL253413A1 (en)	1986-08-12	Biologicaly active agent
DE3466477D1 (en)	1987-11-05	Pharmaceutical formulations
GB2151473B (en)	1987-03-25	Baby's high chair
HUT40648A (en)	1987-01-28	Process for producing optically active substituted 1,4-dihydro-pyridines and pharmaceutical compositions containing them as active agents
AU2532184A (en)	1984-09-13	Active tripeptide derivatives
GB8927997D0 (en)	1990-02-14	Improved c-cores
HUT37764A (en)	1986-02-28	Process for producing 1,4-dihydro-pyrazines and pharmaceutical compositions containing them as active agents
NZ225149A (en)	1991-09-25	Biologically active oligopeptide
AU571579B2 (en)	1988-04-21	Child's wheel chair
CS378887A1 (en)	1988-02-15	Zpusob vyroby n 1butyl n 2(p methylbenzensulfonyl)mocoviny
IE871011L (en)	1987-10-19	Phenyl-piperazine anti-arrhythmia agents
GB8327711D0 (en)	1983-11-16	Antigenically active polypeptide
CS957886A1 (en)	1991-02-12	Active rc-corrector
PL244899A2 (en)	1984-10-08	Formed active carbon
ZA879256B (en)	1988-08-31	Biologically active agent